Page last updated: 2024-10-28

hydroxyurea and Weight Gain

hydroxyurea has been researched along with Weight Gain in 4 studies

Weight Gain: Increase in BODY WEIGHT over existing weight.

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chahoud, I1
Kuriyama, SN1
Paumgartten, FJ1
Louvet, C1
Carrat, F1
Mal, F1
Mabro, M1
Beerblock, K1
Vaillant, JC1
Cady, J1
André, T1
Gamelin, E1
de Gramont, A1
Eggleston, B1
Patience, M1
Edwards, S1
Adamkiewicz, T1
Buchanan, GR1
Davies, SC1
Dickerhoff, R1
Donfield, S1
Feig, SA1
Giller, RH1
Haight, A1
Horan, J1
Hsu, LL1
Kamani, N1
Lane, P1
Levine, JE1
Margolis, D1
Moore, TB1
Ohene-Frempong, K1
Redding-Lallinger, R1
Roberts, IA1
Rogers, ZR2
Sanders, JE1
Scott, JP1
Sleight, B1
Thompson, AA1
Sullivan, KM1
Walters, MC1

Trials

2 trials available for hydroxyurea and Weight Gain

ArticleYear
Effect of myeloablative bone marrow transplantation on growth in children with sickle cell anaemia: results of the multicenter study of haematopoietic cell transplantation for sickle cell anaemia.
    British journal of haematology, 2007, Volume: 136, Issue:4

    Topics: Age Factors; Aging; Anemia, Sickle Cell; Antisickling Agents; Body Height; Bone Marrow Transplantati

2007
Hydroxyurea therapy for diverse pediatric populations with sickle cell disease.
    Seminars in hematology, 1997, Volume: 34, Issue:3 Suppl 3

    Topics: Adolescent; Anemia, Sickle Cell; Blood Transfusion; Child; Child, Preschool; Erythrocyte Indices; Fe

1997

Other Studies

2 other studies available for hydroxyurea and Weight Gain

ArticleYear
Maternal protein-and-energy restriction reduces the developmental toxicity of cyclophosphamide and hydroxyurea in rats.
    Toxicology, 2002, Sep-30, Volume: 179, Issue:1-2

    Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Body Weight; Cyclophosphamide; Di

2002
Prognostic factor analysis in advanced gastric cancer patients treated with hydroxyurea, leucovorin, 5-fluorouracil, and cisplatin (HLFP regimen).
    Cancer investigation, 2003, Volume: 21, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, T

2003